JMJD1C-regulated lipid synthesis contributes to the maintenance of MLL-rearranged acute myeloid leukemia

References

• Winters AC, Bernt KM. MLL-rearranged leukemias—an update on science and clinical approaches. Front Pediatr. 2017;5:4.
   PubMed Web of Science ®Google Scholar
• Röllig C, Bornhäuser M, Thiede C, et al. Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting system. J Clin Oncol. 2011;29(20):2758–2765.
   PubMed Web of Science ®Google Scholar
• Xu X, Schneider B. Therapeutic targeting potential of chromatin-associated proteins in MLL-rearranged acute leukemia. Cell Oncol. 2019;42(2):117–130.
   Web of Science ®Google Scholar
• Sroczynska P, Cruickshank VA, Bukowski JP, et al. ShRNA screening identifies JMJD1C as being required for leukemia maintenance. Blood. 2014;123(12):1870–1882.
   PubMed Web of Science ®Google Scholar
• Zhu N, Chen M, Eng R, et al. MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C. J Clin Invest. 2016;126(3):997–1011.
   PubMed Web of Science ®Google Scholar
• Kim SM, Kim JY, Choe NW, et al. Regulation of mouse steroidogenesis by WHISTLE and JMJD1C through histone methylation balance. Nucleic Acids Res. 2010;38(19):6389–6403.
   PubMed Web of Science ®Google Scholar
• Buerger F, Müller S, Ney N, et al. Depletion of Jmjd1c impairs adipogenesis in murine 3T3-L1 cells. Biochim Biophys Acta Mol Basis Dis. 2017;1863(7):1709–1717.
   PubMed Web of Science ®Google Scholar
• Chasman DI, Paré G, Mora S, et al. Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis. PLOS Genet. 2009;5(11):e1000730.
   PubMed Web of Science ®Google Scholar
• Teslovich TM, Musunuru K, Smith AV, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466(7307):707–713.
   PubMed Web of Science ®Google Scholar
• Tajuddin SM, Schick UM, Eicher JD, et al. Large-scale exome-wide association analysis identifies loci for white blood cell traits and pleiotropy with immune-mediated diseases. Am J Hum Genet. 2016;99(1):22–39.
   PubMed Web of Science ®Google Scholar
• Dorajoo R, Sun Y, Han Y, et al. A genome-wide association study of n-3 and n-6 plasma fatty acids in a Singaporean Chinese population. Genes Nutr. 2015;10(6):53.
   PubMed Web of Science ®Google Scholar
• Jin G, Sun J, Kim S-T, et al. Genome-wide association study identifies a new locus JMJD1C at 10q21 that may influence serum androgen levels in men. Hum Mol Genet. 2012;21(23):5222–5228.
   PubMed Web of Science ®Google Scholar
• Southam AD, Khanim FL, Hayden RE, et al. Drug redeployment to kill leukemia and lymphoma cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids. Cancer Res. 2015;75(12):2530–2540.
   PubMed Web of Science ®Google Scholar
• Subedi A, Liu Q, Sharon D, et al. Nicotinamide phosphoribosyltransferase inhibitors selectively induce apoptosis of AML stem cells by disrupting lipid homeostasis. Cell Stem Cell. 2021;28(10):1851–1867.e8.
   Google Scholar
• Xu X, Wang L, Hu L, et al. Small molecular modulators of JMJD1C preferentially inhibit growth of leukemia cells. Int J Cancer. 2020;146(2):400–412.
   PubMed Web of Science ®Google Scholar
• Dirks W, MacLeod RA, Jäger K, et al. First searchable database for DNA profiles of human cell lines: sequential use of fingerprint techniques for authentication. Cell Mol Biol. 1999;45(6):841–853.
   PubMed Web of Science ®Google Scholar
• Chen C-W, Koche RP, Sinha AU, et al. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia. Nat Med. 2015;21:1–10.
   PubMed Web of Science ®Google Scholar
• Viscarra JA, Wang Y, Nguyen HP, et al. Histone demethylase JMJD1C is phosphorylated by mTOR to activate de novo lipogenesis. Nat Commun. 2020, 11(1):796.
   PubMed Web of Science ®Google Scholar
• Izaguirre-Carbonell J, Christiansen L, Burns R, et al. Critical role of jumonji domain of JMJD1C in MLL-rearranged leukemia. Blood Adv. 2019, 3(9):1499–1511.
   PubMed Web of Science ®Google Scholar
• Watanabe S, Watanabe K, Akimov V, et al. JMJD1C demethylates MDC1 to regulate the RNF8 and BRCA1-mediated chromatin response to DNA breaks. Nat Struct Mol Biol. 2013;20(12):1425–1433.
   PubMed Web of Science ®Google Scholar
• Yokoyama A, Somervaille TCP, Smith KS, et al. The Menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis. Cell. 2005;123(2):207–218.
   PubMed Web of Science ®Google Scholar
• Dzama MM, Taubert MC, Kunz K, et al. Combined targeting of the Menin-MLL1 chromatin complex and FLT3 as a novel therapeutic concept against NPM1 mutant or MLL-Rearranged AML with mutated FLT3. Blood. 2019;134(Supplement_1):1441–1441.
   PubMedGoogle Scholar
• Roongta UV, Pabalan JG, Wang X, et al. Cancer cell dependence on unsaturated fatty acids implicates stearoyl-CoA desaturase as a target for cancer therapy. Mol Cancer Res. 2011, 9(11):1551–61.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Mao C, Yang R, et al. EGLN1/c-Myc induced lymphoid-specific helicase inhibits ferroptosis through lipid metabolic gene expression changes. Theranostics. 2017;7(13):3293–3305.
   PubMed Web of Science ®Google Scholar
• Maeda K, Uysal KT, Makowski L, et al. Role of the fatty acid binding protein mal1 in obesity and insulin resistance. Diabetes. 2003;52(2):300–307.
   PubMed Web of Science ®Google Scholar
• Senga S, Kobayashi N, Kawaguchi K, et al. Fatty acid-binding protein 5 (FABP5) promotes lipolysis of lipid droplets, de novo fatty acid (FA) synthesis and activation of nuclear factor-kappa B (NF-κB) signaling in cancer cells. Biochim Biophys Acta Mol Cell Biol Lipids. 2018, 1863(9):1057–1067.
   PubMed Web of Science ®Google Scholar
• Hasipek M, Guan Y, Grabowski D, et al. Fatty acid binding protein FABP5: a novel therapeutic target in acute myeloid leukemia. Blood. 2019;134(Supplement_1):2553–2553.
   Google Scholar